A study in people with loose skin.
- Who can join
- Adults 45 to 65, women only, have loose skin.
- What you take
- Check ClinicalTrials.gov for this trial's study groups and what each group receives.
- How long it lasts
- The study runs about 7 months.
- What you get
- Costs vary by study. Ask the study team what this one covers, including the study medicine, visits and travel, before you sign the consent form.
What this study is for
Primary condition: Laxity; Skin.
Full scientific study title: Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agon.
Who can join
Adults 45 to 65, women only, have loose skin. A site coordinator confirms whether you qualify during a free screening visit. The exact medical requirements are below.
Full medical eligibility (for you and your doctor)verbatim from the registry
This is the exact wording from ClinicalTrials.gov, including clinical measures (lab values, imaging scores). Bring it to your doctor if any of it is unclear.
Key inclusion criteria
- Post-menopausal women (25 on HRT, 25 non HRT all must be post-menopausal)
- Presence of mild to moderate signs of facial aging (e.g., fine lines, laxity, dull texture) based on modified Griffith scale.
- Adult women aged 45-65 years.
- Fitzpatrick skin types I-VI.
- Current treatment with a stable dose of any GLP-1 agonist medication, including Ozempic, Rybelsus, or Wegovy for at least the last 3 months
Key exclusion criteria
- Non post-menopausal state.
- Any uncontrolled systemic disease.
- History of autoimmune connective tissue disease.
- Current use of immunosuppressive medication.
- Significant history or current evidence of a medical, psychological or other disorder that, in the investigator's opinion, would preclude enrollment into the study.
Where this trial runs
This trial has 1 sites across 1 state. Site contacts are listed for reference. They are not screening through this trial right now.
California1 site
- West Dermatology Research CenterSan Diego, California
Timeline
Scheduled start: April 20, 2026. Expected completion: November 30, 2026. Last updated on ClinicalTrials.gov: April 30, 2026.
Official source
Every Monday we check this trial against ClinicalTrials.gov, the federal registry for clinical research. Last checked September 4, 2026. Confirm the current status there before you contact a site:
Other GLP-1 clinical trials
Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.
